Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to The Dana-Farber Cancer Institute at Londonderry · Londonderry, New Hampshire
Answer a few short questions to share with the research team.